Status:
UNKNOWN
PDS Versus Prolene as Suture Material for Vaginal Sacrospinous Hysteropexy
Lead Sponsor:
Medical University of Vienna
Conditions:
Pelvic Organ Prolapse
Prolapse
Eligibility:
FEMALE
18-100 years
Phase:
NA
Brief Summary
Introduction: Pelvic organ prolapse is a common gynecological disease, which about 50% of women develop in the course of their lives. There are many different options for surgical care, e.g. the uteru...
Eligibility Criteria
Inclusion
- Anterior vaginal wall prolapse beyond the hymen (POP-Q-point Aa or Ba \>0) with central defect
- Prolapse of the apical vaginal vault beyond the hymen (POP-Q point C \>0) with central defect
- Symptoms of a vaginal bulge
- A primary reconstructive operation using sacrospinous hysteropexy is planned
Exclusion
- Recurrent prolapse
- History of hysterectomy
- A primary reconstructive operation with mesh or obliterative surgery is planned
- An operation with hysterectomy is planned
- Known pelvic malignancy
- Known inflammatory disease
- Current systemic treatment with glucocorticoids or immunosuppressants
- The subject cannot or does not want to participate
Key Trial Info
Start Date :
May 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT05964881
Start Date
May 15 2023
End Date
December 1 2025
Last Update
September 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Austria, 1090